{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:11:51Z","timestamp":1793185911347,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ctrv.2018.12.005","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T11:49:54Z","timestamp":1545652194000},"page":"91-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Vulvar malignant melanoma: Pathogenesis, clinical behaviour and management: Review of the literature"],"prefix":"10.1016","volume":"73","author":[{"given":"Florine L.","family":"Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke L.G.","family":"ten Eikelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen H.","family":"Kapiteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carien L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadra","family":"Galaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette I.E.","family":"van Poelgeest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CCO.0b013e32830b0dda","article-title":"Management of melanomas of the female genital tract","volume":"20","author":"Sugiyama","year":"2008","journal-title":"Curr Opin Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2018.12.005_b0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1470-2045(08)70254-7","article-title":"Management of primary melanoma of the female urogenital tract","volume":"9","author":"Piura","year":"2008","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ctrv.2018.12.005_b0015","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1158\/1078-0432.CCR-16-2126","article-title":"Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: a retrospective review of 100 cases","volume":"23","author":"Nagarajan","year":"2017","journal-title":"Clin Cancer Res: An Official J Am Assoc Cancer Res"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0020","article-title":"Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort","volume":"34","author":"Sanchez","year":"2016","journal-title":"Urologic Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/gyno.1998.5188","article-title":"Malignant melanoma of the vagina and locoregional control: radical surgery revisited","volume":"71","author":"Irvin","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0030","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/IGC.0b013e3182980ffb","article-title":"Vulvar\/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities","volume":"23","author":"Mert","year":"2013","journal-title":"Int J Gynecological Cancer: Official J Int Gynecological Cancer Soc"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3892\/ijmm.2014.1659","article-title":"A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker","volume":"33","author":"Heinzelmann-Schwarz","year":"2014","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0040","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3892\/ol.2014.2357","article-title":"Malignant melanoma of the vagina: A case report and review of the literature","volume":"8","author":"Chen","year":"2014","journal-title":"Oncology Lett"},{"issue":"7\u20138","key":"10.1016\/j.ctrv.2018.12.005_b0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10354-015-0354-9","article-title":"Vulvar cancer: a review for dermatologists. Wiener medizinische","volume":"165","author":"Chokoeva","year":"2015","journal-title":"Wochenschrift (1946)"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0050","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/CCO.0000000000000104","article-title":"Management of melanomas of the gynaecological tract","volume":"26","author":"Nobbenhuis","year":"2014","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1590\/S1516-31802010000100008","article-title":"Vulvar melanoma: report on eleven cases and review of the literature","volume":"128","author":"Baiocchi","year":"2010","journal-title":"Sao Paulo Med J = Rev Paul Med"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0060","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ygyno.2014.05.014","article-title":"Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: a population-based study","volume":"134","author":"Akhtar-Danesh","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ygyno.2011.04.007","article-title":"Malignant melanoma of the vulva: an extension of cutaneous melanoma?","volume":"122","author":"Moxley","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ctrv.2018.12.005_b0070","unstructured":"BGCS. Vulval Carcinoma, Guidelines for the Diagnosis and Management of; 2014."},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/cncr.10230","article-title":"Vulvar melanoma: is there a role for sentinel lymph node biopsy?","volume":"94","author":"de Hullu","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2018.12.005_b0080","doi-asserted-by":"crossref","DOI":"10.1097\/LGT.0000000000000204","article-title":"Surgical management and prognostic factors of vulvovaginal melanoma","author":"Ditto","year":"2016","journal-title":"J Lower Genital Tract Dis"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0085","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ygyno.2013.02.028","article-title":"Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy","volume":"129","author":"Janco","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2017.08.023","article-title":"Gynecologic melanomas: A clinicopathologic and molecular analysis","volume":"147","author":"Udager","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2 Pt 1","key":"10.1016\/j.ctrv.2018.12.005_b0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.AOG.0000271209.67461.91","article-title":"Vulvar melanoma: a multivariable analysis of 644 patients","volume":"110","author":"Sugiyama","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0090-8258(92)90300-8","article-title":"Management of vulvar melanoma","volume":"45","author":"Trimble","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ijgc-00009577-200109000-00004","article-title":"Vulvar melanoma at the M. D. Anderson cancer center: 25 years later","volume":"11","author":"Verschraegen","year":"2001","journal-title":"Int J Gynecological Cancer: Official J Int Gynecological Cancer Soc"},{"issue":"7","key":"10.1016\/j.ctrv.2018.12.005_b0110","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/IGC.0000000000000768","article-title":"Prognostic factors of recurrence and survival in vulvar melanoma: subgroup analysis of the VULvar CANcerStudy","volume":"26","author":"Iacoponi","year":"2016","journal-title":"Int J Gynecological Cancer : Official J Int Gynecological Cancer Soc"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CMR.0b013e3282f94636","article-title":"Vulvar melanoma: a report of 10 cases and review of the literature","volume":"18","author":"De Simone","year":"2008","journal-title":"Melanoma Res"},{"issue":"11","key":"10.1016\/j.ctrv.2018.12.005_b0120","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2353::AID-CNCR13>3.0.CO;2-#","article-title":"Malignant melanoma of the vulva. Report of 89 patients","volume":"78","author":"Raber","year":"1996","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0039-6060(98)70073-X","article-title":"Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center","volume":"124","author":"DeMatos","year":"1998","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.ctrv.2018.12.005_b0130","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10434-000-0738-x","article-title":"Prognostic indicators in melanoma of the vulva","volume":"7","author":"Raspagliesi","year":"2000","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1471-0528.1990.tb01737.x","article-title":"Malignant melanoma of the vulva: a clinicopathological study of 50 women","volume":"97","author":"Bradgate","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/gyno.2001.6337","article-title":"Vulvar melanoma: a retrospective analysis and literature review","volume":"83","author":"Irvin","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0145","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jaad.2003.07.026","article-title":"Vulvar melanoma: a report of 20 cases and review of the literature","volume":"50","author":"Wechter","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.ctrv.2018.12.005_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112535","article-title":"Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma","volume":"9","author":"Mehra","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ctrv.2018.12.005_b0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.critrevonc.2017.01.019","article-title":"Mucosal melanoma of the head and neck","volume":"112","author":"Ascierto","year":"2017","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.ctrv.2018.12.005_b0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2017.05.014","article-title":"Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma","volume":"81","author":"Heppt","year":"2017","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"8","key":"10.1016\/j.ctrv.2018.12.005_b0165","first-page":"739","article-title":"Primary mucosal melanomas: a comprehensive review","volume":"5","author":"Mihajlovic","year":"2012","journal-title":"Int J Clin Exp Path"},{"issue":"9195","key":"10.1016\/j.ctrv.2018.12.005_b0170","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(99)00390-6","article-title":"Vulvar melanoma, biologically different from other cutaneous melanomas","volume":"354","author":"Dunton","year":"1999","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0175","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/CMR.0b013e32831993de","article-title":"Primary malignant amelanotic melanoma of the female genital tract: report of two cases and review of literature","volume":"19","author":"An","year":"2009","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02841860410031372","article-title":"Primary malignant melanoma of the vulva\u2013an aggressive tumor for modeling the genesis of non-UV light-associated melanomas","volume":"43","author":"Ragnarsson-Olding","year":"2004","journal-title":"Acta Oncologica (Stockholm, Sweden)"},{"key":"10.1016\/j.ctrv.2018.12.005_b0185","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2011.13320","article-title":"Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma","volume":"141","author":"Dummer","year":"2011","journal-title":"Swiss Medical Weekly"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0190","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00128360-200401000-00012","article-title":"Vulvar melanoma: review of diagnosis, staging, and therapy","volume":"8","author":"Wechter","year":"2004","journal-title":"J Lower Genital Tract Dis"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0195","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/ijgc-00009577-200409000-00021","article-title":"Vulvar cancer patients' quality of life: a qualitative assessment","volume":"14","author":"Janda","year":"2004","journal-title":"Int J Gynecological Cancer: Official J Int Gynecological Cancer Soc"},{"issue":"7","key":"10.1016\/j.ctrv.2018.12.005_b0200","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0002-9378(79)90119-4","article-title":"An alternate approach to early cancer of the vulva","volume":"133","author":"DiSaia","year":"1979","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0205","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jaad.2014.08.019","article-title":"Vulvar nevi, melanosis, and melanoma: an epidemiologic, clinical, and histopathologic review","volume":"71","author":"Murzaku","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ctrv.2018.12.005_b0210","doi-asserted-by":"crossref","unstructured":"Schned L, Mount SL. Unusual neoplasms of the vulva. Diagnostic Histopathology 16(11):517\u201325.","DOI":"10.1016\/j.mpdhp.2010.08.007"},{"key":"10.1016\/j.ctrv.2018.12.005_b0215","unstructured":"Guidelines) NCPGiON. NCCN guideline for patients. Melanoma 2018 Available from: www.nccn.org\/patients\/guielines\/melanoma\/files."},{"key":"10.1016\/j.ctrv.2018.12.005_b0220","unstructured":"Nederlandse Melanoom Werkgroep. Landelijke richtlijn melanoom: oncoline; 2016 [15-06-2018]. Available from: www.oncoline.nl\/melanoom."},{"issue":"9 Suppl 3","key":"10.1016\/j.ctrv.2018.12.005_b0225","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/IGC.0000000000000198","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas","volume":"24","author":"Leitao","year":"2014","journal-title":"Int J Gynecological Cancer: Official J Int Gynecological Cancer Soc"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0090-8258(92)90250-M","article-title":"A clinicopathological study of 30 melanomas of the vulva","volume":"46","author":"Tasseron","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2018.12.005_b0235","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/1097-0142(19940515)73:10<2626::AID-CNCR2820731026>3.0.CO;2-U","article-title":"Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group","volume":"73","author":"Phillips","year":"1994","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0240","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1097-0142(19950101)75:1<72::AID-CNCR2820750113>3.0.CO;2-G","article-title":"Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients","volume":"75","author":"Scheistroen","year":"1995","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0245","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1072-7515(99)00033-2","article-title":"A survey of hospital management practices for vulvar melanoma","volume":"188","author":"Creasman","year":"1999","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0250","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2011.11.921","article-title":"Clinicopathologic study of 85 cases of melanoma of the female genitalia","volume":"67","author":"Tcheung","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0255","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1245\/s10434-014-4215-3","article-title":"Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases","volume":"22","author":"Seifried","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2018.12.005_b0260","unstructured":"Control UfIC. TNM classification of malignant tumours 2016 [01-06-2018]. Available from: www.hoofdhalskanker.info\/wpavl\/wp-content\/uploads\/TNM-Classification-of-Malignant-Tumours-8th-edition."},{"issue":"7","key":"10.1016\/j.ctrv.2018.12.005_b0265","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1285::AID-CNCR25>3.0.CO;2-P","article-title":"Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival","volume":"86","author":"Ragnarsson-Olding","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0090-8258(83)90090-2","article-title":"Melanoma of the vulva: an update","volume":"16","author":"Podratz","year":"1983","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0275","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00004347-198609000-00002","article-title":"Malignant melanoma of the vulva: a clinical-pathologic review of 16 cases","volume":"5","author":"Benda","year":"1986","journal-title":"Int J Gynecological Pathology: Official J Int Soc Gynecological Pathologists"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0280","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ejso.2015.01.002","article-title":"Clitoral involvement of squamous cell carcinoma of the vulva: localization with the worst prognosis","volume":"41","author":"Hinten","year":"2015","journal-title":"Eur J Surg Oncol: The J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"16","key":"10.1016\/j.ctrv.2018.12.005_b0285","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American joint committee on cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol: Official J Am Soc Clin Oncol"},{"key":"10.1016\/j.ctrv.2018.12.005_b0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/IJWH.S68979","article-title":"Vulvar cancer: epidemiology, clinical presentation, and management options","volume":"7","author":"Alkatout","year":"2015","journal-title":"Int J Women's Health"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0295","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s13304-015-0303-6","article-title":"Recent trends in surgical and reconstructive management of vulvar cancer: review of literature","volume":"67","author":"Vitale","year":"2015","journal-title":"Updates Surg"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0300","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ijrobp.2014.03.042","article-title":"Mucosal melanoma of the head and neck: a systematic review of the literature","volume":"90","author":"Lazarev","year":"2014","journal-title":"Int J Radiation Oncol \u2022 Biol \u2022 Phys"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.anorl.2010.04.006","article-title":"Sinonasal mucosal melanomas","volume":"127","author":"Lietin","year":"2010","journal-title":"Eur Ann Otorhinolaryngology, Head and Neck Dis"},{"issue":"9","key":"10.1016\/j.ctrv.2018.12.005_b0310","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/cncr.24976","article-title":"Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center","volume":"116","author":"Moreno","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0315","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s00259-009-1358-8","article-title":"Sentinel node detection by lymphoscintigraphy and sentinel lymph node biopsy in vulvar melanoma","volume":"37","author":"Trifiro","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.ctrv.2018.12.005_b0320","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/BF02557519","article-title":"Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review","volume":"9","author":"Abramova","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0325","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/ijgc-00009577-200705000-00024","article-title":"Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature","volume":"17","author":"Dhar","year":"2007","journal-title":"Int J Gynecological Cancer: Official J Int Gynecological Cancer Soc"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0330","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00259-006-0237-9","article-title":"Validation and application of the sentinel lymph node concept in malignant vulvar tumours","volume":"34","author":"Vidal-Sicart","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0335","first-page":"163","article-title":"Intraoperative lymphatic mapping for vulvar cancer","volume":"84","author":"Levenback","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0340","first-page":"1249","article-title":"Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study","volume":"6","author":"Rodier","year":"1999","journal-title":"Oncol Rep"},{"issue":"Suppl 5","key":"10.1016\/j.ctrv.2018.12.005_b0345","doi-asserted-by":"crossref","first-page":"v126","DOI":"10.1093\/annonc\/mdv297","article-title":"Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Dummer","year":"2015","journal-title":"Ann Oncol: Official J Eur Soc Med Oncol"},{"issue":"23","key":"10.1016\/j.ctrv.2018.12.005_b0350","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","article-title":"Sentinel lymph node biopsy for melanoma: American society of clinical oncology and society of surgical oncology joint clinical practice guideline","volume":"30","author":"Wong","year":"2012","journal-title":"J Clin Oncol: Official J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2018.12.005_b0355","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"The New Engl J Med"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0360","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.clindermatol.2012.08.009","article-title":"The role of radiotherapy in the overall treatment of melanoma","volume":"31","author":"Forschner","year":"2013","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0365","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0039-6109(02)00096-8","article-title":"Radiation therapy for malignant melanoma","volume":"83","author":"Ballo","year":"2003","journal-title":"Surg Clinics North Am"},{"issue":"9","key":"10.1016\/j.ctrv.2018.12.005_b0370","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hed.24435","article-title":"Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response","volume":"38","author":"Samstein Robert","year":"2016","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0375","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hed.10263","article-title":"Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma","volume":"25","author":"Vongtama","year":"2003","journal-title":"Head Neck"},{"issue":"Suppl 6","key":"10.1016\/j.ctrv.2018.12.005_b0380","first-page":"vi22-9","article-title":"Surgery and radiotherapy in the treatment of cutaneous melanoma","volume":"20","author":"Testori","year":"2009","journal-title":"Ann Oncology: Official J Eur Soc Med Oncol"},{"key":"10.1016\/j.ctrv.2018.12.005_b0385","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gore.2016.04.001","article-title":"Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract","volume":"16","author":"Schiavone","year":"2016","journal-title":"Gynecologic Oncol Rep"},{"issue":"9","key":"10.1016\/j.ctrv.2018.12.005_b0390","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(15)00187-4","article-title":"Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02\/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial","volume":"16","author":"Henderson","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/v10019-010-0008-x","article-title":"Role of radiotherapy in melanoma management","volume":"44","author":"Strojan","year":"2010","journal-title":"Radiol Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2018.12.005_b0400","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/cncr.28415","article-title":"The role of adjuvant radiotherapy in the local management of desmoplastic melanoma","volume":"120","author":"Guadagnolo","year":"2014","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.ctrv.2018.12.005_b0405","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1158\/1078-0432.CCR-13-0739","article-title":"Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma","volume":"19","author":"Lian","year":"2013","journal-title":"Clin Cancer Res: An Official J Am Assoc Cancer Res"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0410","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008390-200412000-00012","article-title":"Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma","volume":"14","author":"Harting","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ctrv.2018.12.005_b0415","first-page":"Cd008955","article-title":"Interferon alpha for the adjuvant treatment of cutaneous melanoma","volume":"6","author":"Mocellin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0420","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/IGC.0000000000000013","article-title":"Primary malignant melanoma of the vagina: a retrospective clinicopathologic study of 44 cases","volume":"24","author":"Xia","year":"2014","journal-title":"Int J Gynecological Cancer: Official J Int Gynecological Cancer Soc"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0425","first-page":"619","article-title":"Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients","volume":"70","author":"Creagan","year":"1986","journal-title":"Cancer Treat Rep"},{"issue":"7","key":"10.1016\/j.ctrv.2018.12.005_b0430","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2005.04.3216","article-title":"Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma","volume":"24","author":"Dummer","year":"2006","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"14","key":"10.1016\/j.ctrv.2018.12.005_b0435","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"The New Engl J Med"},{"issue":"19","key":"10.1016\/j.ctrv.2018.12.005_b0440","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"The New Engl J Med"},{"issue":"26","key":"10.1016\/j.ctrv.2018.12.005_b0445","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"The New Engl J Med"},{"issue":"19","key":"10.1016\/j.ctrv.2018.12.005_b0450","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"The New Engl J Med"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0455","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1111\/jdv.14486","article-title":"Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?","volume":"32","author":"Quereux","year":"2018","journal-title":"J Eur Acad Dermatology Venereology: JEADV"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0460","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5694\/mja13.10448","article-title":"Ipilimumab in pretreated patients with unresectable or metastatic cutaneous, uveal and mucosal melanoma","volume":"201","author":"Alexander","year":"2014","journal-title":"Med J Australia"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0465","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-4632.2012.05829.x","article-title":"Molecularly targeted therapies for melanoma","volume":"52","author":"Liu","year":"2013","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0470","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmg.2003.016667","article-title":"Absence of BRAF mutations in UV-protected mucosal melanomas","volume":"41","author":"Edwards","year":"2004","journal-title":"J Med Genet"},{"issue":"10","key":"10.1016\/j.ctrv.2018.12.005_b0475","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1158\/1078-0432.CCR-03-0562","article-title":"Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin Cancer Res: An Official J Am Assoc Cancer Res"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0480","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jcp.2004.022509","article-title":"BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs","volume":"58","author":"Wong","year":"2005","journal-title":"J Clin Pathol"},{"issue":"12","key":"10.1016\/j.ctrv.2018.12.005_b0485","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-10-2917","article-title":"KIT pathway alterations in mucosal melanomas of the vulva and other sites","volume":"17","author":"Omholt","year":"2011","journal-title":"Clin Cancer Res: An Official J Am Assoc Cancer Res"},{"issue":"22","key":"10.1016\/j.ctrv.2018.12.005_b0490","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ctrv.2018.12.005_b0495","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2014.04.056","article-title":"NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract\u2013a study of 24 cases from the Netherlands","volume":"134","author":"van Engen-van Grunsven","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0500","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaad.2014.03.033","article-title":"Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract","volume":"71","author":"Tseng","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"et al.10","key":"10.1016\/j.ctrv.2018.12.005_b0505","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/modpathol.2013.211","article-title":"Comparison of molecular abnormalities in vulvar and vaginal melanomas","volume":"27","author":"Aulmann","year":"2014","journal-title":"Modern Pathol: An Official J United States Can Acad Pathol, Inc."},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0510","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/LGT.0000000000000142","article-title":"Malignant melanoma of vulva and vagina: a histomorphological review and mutation analysis\u2013a single-center study","volume":"19","author":"Rouzbahman","year":"2015","journal-title":"J Lower Genital Tract Dis"},{"issue":"8","key":"10.1016\/j.ctrv.2018.12.005_b0515","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cncr.30473","article-title":"Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma","volume":"123","author":"Hou","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0520","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/bjd.15836","article-title":"KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas","volume":"177","author":"Dias-Santagata","year":"2017","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.ctrv.2018.12.005_b0525","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/jdv.14353","article-title":"Mucosal melanoma: clinical, histological and c-kit gene mutational profile of 86 French cases","volume":"31","author":"Cinotti","year":"2017","journal-title":"J Eur Acad Dermatol Venereol: JEADV"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0530","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/exd.13472","article-title":"BRAF mutations might be more common than supposed in vulvar melanomas","volume":"27","author":"Wylomanski","year":"2018","journal-title":"Exp Dermatol"},{"issue":"11","key":"10.1016\/j.ctrv.2018.12.005_b0535","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/modpathol.2009.116","article-title":"Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous\/mucosal type","volume":"22","author":"Torres-Cabala","year":"2009","journal-title":"Modern Pathol: An Official J United States Can Acad Pathol, Inc."},{"issue":"12","key":"10.1016\/j.ctrv.2018.12.005_b0540","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ejca.2012.02.049","article-title":"Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations","volume":"48","author":"Schoenewolf","year":"2012","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2018.12.005_b0545","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2310\/7750.2011.11064","article-title":"KIT gene mutations and patterns of protein expression in mucosal and acral melanoma","volume":"16","author":"Abu-Abed","year":"2012","journal-title":"J Cutaneous Med Surg"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0550","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1523-1747.1998.00376.x","article-title":"N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin","volume":"111","author":"Jiveskog","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"26","key":"10.1016\/j.ctrv.2018.12.005_b0555","doi-asserted-by":"crossref","first-page":"3182-+","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2018.12.005_b0560","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-11-1987","article-title":"Sunitinib therapy for melanoma patients with KIT mutations","volume":"18","author":"Minor","year":"2012","journal-title":"Clin Cancer Res: An Official J Am Assoc Cancer Res"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0565","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/annonc\/mdx079","article-title":"Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial","volume":"28","author":"Guo","year":"2017","journal-title":"Ann Oncol"},{"issue":"47","key":"10.1016\/j.ctrv.2018.12.005_b0570","doi-asserted-by":"crossref","first-page":"82661","DOI":"10.18632\/oncotarget.19746","article-title":"The clinical significance of c-Kit mutations in metastatic oral mucosal melanoma in China","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ctrv.2018.12.005_b0575","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2016.04.021","article-title":"Rare vulvar malignancies; incidence, treatment and survival in the Netherlands","volume":"142","author":"Pleunis","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2018.12.005_b0580","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00006250-197506000-00008","article-title":"Malignant melanoma of the vulva: A report of 44 cases","volume":"45","author":"Chung","year":"1975","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ctrv.2018.12.005_b0585","first-page":"18","article-title":"A global review of melanoma follow-up guidelines","volume":"6","author":"Trotter","year":"2013","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"4","key":"10.1016\/j.ctrv.2018.12.005_b0590","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jso.2930500408","article-title":"Malignant melanoma of the vulva: a clinicopathologic study of 18 cases","volume":"50","author":"Piura","year":"1992","journal-title":"J Surg Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737218302093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737218302093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T09:21:56Z","timestamp":1759656116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737218302093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":118,"alternative-id":["S0305737218302093"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2018.12.005","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vulvar malignant melanoma: Pathogenesis, clinical behaviour and management: Review of the literature","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}